Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
出版年份 2021 全文链接
标题
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2021-04-24
DOI
10.1021/acs.jmedchem.1c00509
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
- (2021) Kas Steuten et al. ACS Infectious Diseases
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- COVID-19: Drug Targets and Potential Treatments
- (2020) Carmen Gil et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
- (2020) Athri D. Rathnayake et al. Science Translational Medicine
- Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry
- (2020) Zachary A. Gurard-Levin et al. ANTIVIRAL RESEARCH
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
- (2020) Wioletta Rut et al. Nature Chemical Biology
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
- (2020) Jian Li et al. Science Bulletin
- Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor
- (2019) Rami Musharrafieh et al. JOURNAL OF VIROLOGY
- Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease
- (2019) Yuying Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Can Cysteine Protease Cross-class Inhibitors Achieve Selectivity?
- (2019) Lorenzo Cianni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance
- (2018) Jiantao Zhang et al. Scientific Reports
- Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
- (2017) Niels C Pedersen et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
- (2016) Yunjeong Kim et al. PLoS Pathogens
- Bayesian Deconvolution of Mass and Ion Mobility Spectra: From Binary Interactions to Polydisperse Ensembles
- (2015) Michael T. Marty et al. ANALYTICAL CHEMISTRY
- Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
- (2015) Marton Siklos et al. Acta Pharmaceutica Sinica B
- Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
- (2013) Mark Turlington et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
- (2012) Jon Jacobs et al. JOURNAL OF MEDICINAL CHEMISTRY
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Specific Binding of Adamantane Drugs and Direction of Their Polar Amines in the Pore of the Influenza M2 Transmembrane Domain in Lipid Bilayers and Dodecylphosphocholine Micelles Determined by NMR Spectroscopy
- (2011) Sarah D. Cady et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Neutral red uptake assay for the estimation of cell viability/cytotoxicity
- (2008) Guillermo Repetto et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started